drugset / Trial / NCT02068157

Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer

NCT02068157

NaSingle-groupOpen-labelTreatment

Summary

This phase II trial studies the effects of interstitial photodynamic therapy in patients with head and neck cancer that has come back. Interstitial photodynamic therapy uses a combination of laser light and a light-sensitive drug called porfimer sodium to destroy tumors. During treatment a laser light is used to activate the drug. Interstitial photodynamic therapy may be an effective treatment for head and neck cancer.

Timeline

Start
2014-04-01
Primary completion
2016-10-13
Completion
2016-11-04

Drugs

EvaluationDrugModalityDoseRoute
Subject porfimer sodium Small molecule Intravenous